Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction
Journal of Clinical Microbiology · 2023
DOI: 10.1128/jcm.01578-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2023. Verfasst von Kayzad Nilgiriwala und 16 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Medical Research, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome Trust Institutional Strategic Support Fund, Wellcome Trust Clinical Career Development Fellow.
Abstract (Originalsprache)
Universal access to drug susceptibility testing for newly diagnosed tuberculosis patients is recommended. Access to culture-based diagnostics remains limited, and targeted molecular assays are vulnerable to emerging resistance mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Foundation for Medical Research, Mumbai, Maharashtra, India.
- Mycobacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
- European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridgeshire, United Kingdom.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
- Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford, United Kingdom.
- Immunopathology Axis, Centre de Recherche du Centre Hospitalier, Université de Montréal, Montréal, Québec, Canada.
ORCID-Profile: Kate Dingle, Niaina Rakotosamimanana, Simon Grandjean Lapierre
Förderung
- Wellcome Trust
- Wellcome Trust Institutional Strategic Support Fund
- Wellcome Trust Clinical Career Development Fellow
- Australian Medical Research Future Fund
- Fonds de Recherche Québec Santé
Zitieren
APA
Nilgiriwala, K., Rabodoarivelo, M. S., Hall, M. B., Patel, G., Mandal, A., Mishra, S., Andrianomanana, F. R., Dingle, K., Rodger, G., George, S., Crook, D. W., Hoosdally, S., Mistry, N., Rakotosamimanana, N., Iqbal, Z., Grandjean Lapierre, S., & Walker, T. M. (2023). Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01578-22
Vancouver
Nilgiriwala K, Rabodoarivelo MS, Hall MB, Patel G, Mandal A, Mishra S, et al. Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction. Journal of Clinical Microbiology. 2023. doi:10.1128/jcm.01578-22
BibTeX
@article{Nilgiriwala2023,
author = {Nilgiriwala, Kayzad and Rabodoarivelo, Marie-Sylvianne and Hall, Michael B and Patel, Grishma and Mandal, Ayan and Mishra, Shefali and Andrianomanana, Fanantenana Randria and Dingle, Kate and Rodger, Gillian and George, Sophie and Crook, Derrick W and Hoosdally, Sarah and Mistry, Nerges and Rakotosamimanana, Niaina and Iqbal, Zamin and Grandjean Lapierre, Simon and Walker, Timothy M},
title = {Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction},
journal = {Journal of Clinical Microbiology},
year = {2023},
doi = {10.1128/jcm.01578-22}
}
EUVIMED